Regulatory Strategies To Leverage New and Rapidly Evolving Accelerated Pathways

April 25, 2018
Learn about the following topics from PAREXEL Consulting experts in this recorded webinar: 1. Opportunities and challenges presented by accelerated pathway designations; 2. FDA frameworks for developing targeted therapies; 3. How to leverage intermediate clinical endpoints and novel biomarkers; 4. How to use real world evidence and patient preference data; and 5. The importance of early engagement with EU regulators and payers.
Previous Video
Decoding Insights from Wearables in Clinical Trials Where to Start
Decoding Insights from Wearables in Clinical Trials Where to Start

Within clinical trials, there is optimism that connected wearables, sensors and other medical devices can b...

Next Video
PAREXEL Informatics: Decoding Data into Insights
PAREXEL Informatics: Decoding Data into Insights

PAREXEL® Informatics is at the forefront of innovation and driving evolution by looking at technology and d...